Nivolumab for Recurrent or Progressive IDH Mutant Gliomas
Clinical trial NCT03557359 · COMPLETED
Trial details
- NCT number
- NCT03557359
- Sponsor
- Fabio Iwamoto, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2022-09-20
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.